Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemoglobinopathy Testing Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Hydroxyurea
1.2.3 Glutamine
1.2.4 Zynteglo
1.2.5 Luspatercept
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hemoglobinopathy Testing Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Sickle Cell Diseases
1.3.3 Thalassemia
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemoglobinopathy Testing Services Market Perspective (2018-2029)
2.2 Hemoglobinopathy Testing Services Growth Trends by Region
2.2.1 Global Hemoglobinopathy Testing Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hemoglobinopathy Testing Services Historic Market Size by Region (2018-2024)
2.2.3 Hemoglobinopathy Testing Services Forecasted Market Size by Region (2024-2029)
2.3 Hemoglobinopathy Testing Services Market Dynamics
2.3.1 Hemoglobinopathy Testing Services Industry Trends
2.3.2 Hemoglobinopathy Testing Services Market Drivers
2.3.3 Hemoglobinopathy Testing Services Market Challenges
2.3.4 Hemoglobinopathy Testing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemoglobinopathy Testing Services Players by Revenue
3.1.1 Global Top Hemoglobinopathy Testing Services Players by Revenue (2018-2024)
3.1.2 Global Hemoglobinopathy Testing Services Revenue Market Share by Players (2018-2024)
3.2 Global Hemoglobinopathy Testing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hemoglobinopathy Testing Services Revenue
3.4 Global Hemoglobinopathy Testing Services Market Concentration Ratio
3.4.1 Global Hemoglobinopathy Testing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemoglobinopathy Testing Services Revenue in 2022
3.5 Hemoglobinopathy Testing Services Key Players Head office and Area Served
3.6 Key Players Hemoglobinopathy Testing Services Product Solution and Service
3.7 Date of Enter into Hemoglobinopathy Testing Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemoglobinopathy Testing Services Breakdown Data by Type
4.1 Global Hemoglobinopathy Testing Services Historic Market Size by Type (2018-2024)
4.2 Global Hemoglobinopathy Testing Services Forecasted Market Size by Type (2024-2029)
5 Hemoglobinopathy Testing Services Breakdown Data by Application
5.1 Global Hemoglobinopathy Testing Services Historic Market Size by Application (2018-2024)
5.2 Global Hemoglobinopathy Testing Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Hemoglobinopathy Testing Services Market Size (2018-2029)
6.2 North America Hemoglobinopathy Testing Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Hemoglobinopathy Testing Services Market Size by Country (2018-2024)
6.4 North America Hemoglobinopathy Testing Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hemoglobinopathy Testing Services Market Size (2018-2029)
7.2 Europe Hemoglobinopathy Testing Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Hemoglobinopathy Testing Services Market Size by Country (2018-2024)
7.4 Europe Hemoglobinopathy Testing Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemoglobinopathy Testing Services Market Size (2018-2029)
8.2 Asia-Pacific Hemoglobinopathy Testing Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Hemoglobinopathy Testing Services Market Size by Region (2018-2024)
8.4 Asia-Pacific Hemoglobinopathy Testing Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hemoglobinopathy Testing Services Market Size (2018-2029)
9.2 Latin America Hemoglobinopathy Testing Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Hemoglobinopathy Testing Services Market Size by Country (2018-2024)
9.4 Latin America Hemoglobinopathy Testing Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemoglobinopathy Testing Services Market Size (2018-2029)
10.2 Middle East & Africa Hemoglobinopathy Testing Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Hemoglobinopathy Testing Services Market Size by Country (2018-2024)
10.4 Middle East & Africa Hemoglobinopathy Testing Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Hemoglobinopathy Testing Services Introduction
11.1.4 Novartis Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.1.5 Novartis Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Hemoglobinopathy Testing Services Introduction
11.2.4 AstraZeneca Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.2.5 AstraZeneca Recent Development
11.3 Bluebird Bio
11.3.1 Bluebird Bio Company Detail
11.3.2 Bluebird Bio Business Overview
11.3.3 Bluebird Bio Hemoglobinopathy Testing Services Introduction
11.3.4 Bluebird Bio Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.3.5 Bluebird Bio Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Hemoglobinopathy Testing Services Introduction
11.4.4 Bristol-Myers Squibb Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Emmaus Medical
11.5.1 Emmaus Medical Company Detail
11.5.2 Emmaus Medical Business Overview
11.5.3 Emmaus Medical Hemoglobinopathy Testing Services Introduction
11.5.4 Emmaus Medical Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.5.5 Emmaus Medical Recent Development
11.6 Acceleron Pharma
11.6.1 Acceleron Pharma Company Detail
11.6.2 Acceleron Pharma Business Overview
11.6.3 Acceleron Pharma Hemoglobinopathy Testing Services Introduction
11.6.4 Acceleron Pharma Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.6.5 Acceleron Pharma Recent Development
11.7 HemaQuest Pharmaceuticals
11.7.1 HemaQuest Pharmaceuticals Company Detail
11.7.2 HemaQuest Pharmaceuticals Business Overview
11.7.3 HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Introduction
11.7.4 HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.7.5 HemaQuest Pharmaceuticals Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Detail
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Hemoglobinopathy Testing Services Introduction
11.8.4 Eli Lilly and Company Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.8.5 Eli Lilly and Company Recent Development
11.9 Celgene Corporation
11.9.1 Celgene Corporation Company Detail
11.9.2 Celgene Corporation Business Overview
11.9.3 Celgene Corporation Hemoglobinopathy Testing Services Introduction
11.9.4 Celgene Corporation Revenue in Hemoglobinopathy Testing Services Business (2018-2024)
11.9.5 Celgene Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hemoglobinopathy Testing Services Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Hydroxyurea
Table 3. Key Players of Glutamine
Table 4. Key Players of Zynteglo
Table 5. Key Players of Luspatercept
Table 6. Key Players of Others
Table 7. Global Hemoglobinopathy Testing Services Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Hemoglobinopathy Testing Services Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Hemoglobinopathy Testing Services Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global Hemoglobinopathy Testing Services Market Share by Region (2018-2024)
Table 11. Global Hemoglobinopathy Testing Services Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Hemoglobinopathy Testing Services Market Share by Region (2024-2029)
Table 13. Hemoglobinopathy Testing Services Market Trends
Table 14. Hemoglobinopathy Testing Services Market Drivers
Table 15. Hemoglobinopathy Testing Services Market Challenges
Table 16. Hemoglobinopathy Testing Services Market Restraints
Table 17. Global Hemoglobinopathy Testing Services Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global Hemoglobinopathy Testing Services Market Share by Players (2018-2024)
Table 19. Global Top Hemoglobinopathy Testing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathy Testing Services as of 2022)
Table 20. Ranking of Global Top Hemoglobinopathy Testing Services Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Hemoglobinopathy Testing Services Revenue (CR5 and HHI) & (2018-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hemoglobinopathy Testing Services Product Solution and Service
Table 24. Date of Enter into Hemoglobinopathy Testing Services Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hemoglobinopathy Testing Services Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global Hemoglobinopathy Testing Services Revenue Market Share by Type (2018-2024)
Table 28. Global Hemoglobinopathy Testing Services Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Hemoglobinopathy Testing Services Revenue Market Share by Type (2024-2029)
Table 30. Global Hemoglobinopathy Testing Services Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global Hemoglobinopathy Testing Services Revenue Market Share by Application (2018-2024)
Table 32. Global Hemoglobinopathy Testing Services Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Hemoglobinopathy Testing Services Revenue Market Share by Application (2024-2029)
Table 34. North America Hemoglobinopathy Testing Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Hemoglobinopathy Testing Services Market Size by Country (2018-2024) & (US$ Million)
Table 36. North America Hemoglobinopathy Testing Services Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Hemoglobinopathy Testing Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Hemoglobinopathy Testing Services Market Size by Country (2018-2024) & (US$ Million)
Table 39. Europe Hemoglobinopathy Testing Services Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Hemoglobinopathy Testing Services Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Hemoglobinopathy Testing Services Market Size by Region (2018-2024) & (US$ Million)
Table 42. Asia-Pacific Hemoglobinopathy Testing Services Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Hemoglobinopathy Testing Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Hemoglobinopathy Testing Services Market Size by Country (2018-2024) & (US$ Million)
Table 45. Latin America Hemoglobinopathy Testing Services Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Hemoglobinopathy Testing Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Hemoglobinopathy Testing Services Market Size by Country (2018-2024) & (US$ Million)
Table 48. Middle East & Africa Hemoglobinopathy Testing Services Market Size by Country (2024-2029) & (US$ Million)
Table 49. Novartis Company Detail
Table 50. Novartis Business Overview
Table 51. Novartis Hemoglobinopathy Testing Services Product
Table 52. Novartis Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 53. Novartis Recent Development
Table 54. AstraZeneca Company Detail
Table 55. AstraZeneca Business Overview
Table 56. AstraZeneca Hemoglobinopathy Testing Services Product
Table 57. AstraZeneca Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 58. AstraZeneca Recent Development
Table 59. Bluebird Bio Company Detail
Table 60. Bluebird Bio Business Overview
Table 61. Bluebird Bio Hemoglobinopathy Testing Services Product
Table 62. Bluebird Bio Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 63. Bluebird Bio Recent Development
Table 64. Bristol-Myers Squibb Company Detail
Table 65. Bristol-Myers Squibb Business Overview
Table 66. Bristol-Myers Squibb Hemoglobinopathy Testing Services Product
Table 67. Bristol-Myers Squibb Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 68. Bristol-Myers Squibb Recent Development
Table 69. Emmaus Medical Company Detail
Table 70. Emmaus Medical Business Overview
Table 71. Emmaus Medical Hemoglobinopathy Testing Services Product
Table 72. Emmaus Medical Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 73. Emmaus Medical Recent Development
Table 74. Acceleron Pharma Company Detail
Table 75. Acceleron Pharma Business Overview
Table 76. Acceleron Pharma Hemoglobinopathy Testing Services Product
Table 77. Acceleron Pharma Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 78. Acceleron Pharma Recent Development
Table 79. HemaQuest Pharmaceuticals Company Detail
Table 80. HemaQuest Pharmaceuticals Business Overview
Table 81. HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Product
Table 82. HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 83. HemaQuest Pharmaceuticals Recent Development
Table 84. Eli Lilly and Company Company Detail
Table 85. Eli Lilly and Company Business Overview
Table 86. Eli Lilly and Company Hemoglobinopathy Testing Services Product
Table 87. Eli Lilly and Company Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 88. Eli Lilly and Company Recent Development
Table 89. Celgene Corporation Company Detail
Table 90. Celgene Corporation Business Overview
Table 91. Celgene Corporation Hemoglobinopathy Testing Services Product
Table 92. Celgene Corporation Revenue in Hemoglobinopathy Testing Services Business (2018-2024) & (US$ Million)
Table 93. Celgene Corporation Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemoglobinopathy Testing Services Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Hemoglobinopathy Testing Services Market Share by Type: 2022 VS 2029
Figure 3. Hydroxyurea Features
Figure 4. Glutamine Features
Figure 5. Zynteglo Features
Figure 6. Luspatercept Features
Figure 7. Others Features
Figure 8. Global Hemoglobinopathy Testing Services Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Hemoglobinopathy Testing Services Market Share by Application: 2022 VS 2029
Figure 10. Sickle Cell Diseases Case Studies
Figure 11. Thalassemia Case Studies
Figure 12. Other Case Studies
Figure 13. Hemoglobinopathy Testing Services Report Years Considered
Figure 14. Global Hemoglobinopathy Testing Services Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Hemoglobinopathy Testing Services Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Hemoglobinopathy Testing Services Market Share by Region: 2022 VS 2029
Figure 17. Global Hemoglobinopathy Testing Services Market Share by Players in 2022
Figure 18. Global Top Hemoglobinopathy Testing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathy Testing Services as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Hemoglobinopathy Testing Services Revenue in 2022
Figure 20. North America Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Hemoglobinopathy Testing Services Market Share by Country (2018-2029)
Figure 22. United States Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Hemoglobinopathy Testing Services Market Share by Country (2018-2029)
Figure 26. Germany Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Hemoglobinopathy Testing Services Market Share by Region (2018-2029)
Figure 34. China Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Hemoglobinopathy Testing Services Market Share by Country (2018-2029)
Figure 42. Mexico Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Hemoglobinopathy Testing Services Market Share by Country (2018-2029)
Figure 46. Turkey Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Hemoglobinopathy Testing Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Novartis Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 49. AstraZeneca Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 50. Bluebird Bio Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 52. Emmaus Medical Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 53. Acceleron Pharma Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 54. HemaQuest Pharmaceuticals Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 55. Eli Lilly and Company Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 56. Celgene Corporation Revenue Growth Rate in Hemoglobinopathy Testing Services Business (2018-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed